QUIA PHARMA
0.00 SEK
-25.00 %
Less than 1K followers
QUIA
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-25.00 %
-73.91 %
-84.21 %
-87.23 %
-92.97 %
-95.94 %
-99.99 %
-100.00 %
-100.00 %
QUIA PHARMA operates in medical technology. The company has developed a technological platform that is used to develop existing pharmaceuticals. The technology is based on what is known as PEGylation, a technique that connects water-soluble polymers with the pharmaceuticals and is used to improve various characteristics in the biopharmaceuticals in regards to stability and resistance.
Read moreMarket cap
1.18M SEK
Turnover
25.87K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
26.2
2026
Annual report '25
All
Press releases
ShowingAll content types
QuiaPEG has submitted a formal application to Nasdaq for the reverse acquisition of Rosemonkey Ltd.
QuiaPEG och Net Zero Infrastucture take next step to a formal license agreement
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools